These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 228924)

  • 1. Pyrogastrone for oesophagitis.
    Drug Ther Bull; 1979 Aug; 17(16):63-4. PubMed ID: 228924
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period.
    Markham C; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():73-82. PubMed ID: 6259715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of pyrogastrone and cimetidine in the treatment of reflux oesophagitis.
    Maxton DG; Heald J; Whorwell PJ; Haboubi NY
    Gut; 1990 Mar; 31(3):351-4. PubMed ID: 2157637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oesophagitis and the role of antacid therapy.
    Rhodes J
    Scand J Gastroenterol Suppl; 1982; 75():74-6. PubMed ID: 6959253
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 8. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 11. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

  • 13. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastroesophageal reflux. Results of a multicenter study of 170 patients on the therapeutic value of the Gaviscon drinkable suspension].
    Chevrel B
    Med Chir Dig; 1980; 9(6):535-9. PubMed ID: 6259459
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerance of Algicon in patients with reflux oesophagitis.
    Lancaster Smith MJ; Miller JP; Whorwell PJ
    Br J Clin Pract Suppl; 1989 Feb; 66():38-42; discussion 61-4. PubMed ID: 2511921
    [No Abstract]   [Full Text] [Related]  

  • 16. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis.
    Maxton DG; Miller JP; Whorwell PJ; Butler JK
    Br J Clin Pract; 1988 Sep; 42(9):368-71. PubMed ID: 3075928
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of Algicon on the ultrastructure of the mucosa of subjects with reflux oesophagitis.
    Trabucchi E; Foschi D; Radaelli E; Callioni F; Montorsi W
    Br J Clin Pract Suppl; 1989 Feb; 66():43-7; discussion 61-4. PubMed ID: 2511922
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of medical management of gastroesophageal reflux: a critical assessment.
    Hollander D; Karris G
    South Med J; 1978 Jan; 71 Suppl 1():41-2. PubMed ID: 204059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.